Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.31

(-2.24%)

Net Income Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual net income in 2023 was -281.19 Million USD , up 21.23% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly net income in 2024 Q2 was -48.88 Million USD , down -1.64% from previous quarter.
  • Curaleaf Holdings, Inc. reported an annual net income of -481.81 Million USD in 2022, down -86.61% from previous year.
  • Curaleaf Holdings, Inc. reported an annual net income of -258.19 Million USD in 2021, down -236.76% from previous year.
  • Curaleaf Holdings, Inc. reported a quarterly net income of -65.15 Million USD for 2024 Q1, up 25.98% from previous quarter.
  • Curaleaf Holdings, Inc. reported a quarterly net income of -123.86 Million USD for 2023 Q3, down -29.45% from previous quarter.

Annual Net Income Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual Net Income of Curaleaf Holdings, Inc. (2023 - 2016)

Year Net Income Net Income Growth
2023 -281.19 Million USD 21.23%
2022 -481.81 Million USD -86.61%
2021 -258.19 Million USD -236.76%
2020 -76.67 Million USD 14.07%
2019 -89.22 Million CAD -21.91%
2018 -73.18 Million CAD -1900.92%
2017 -3.65 Million CAD -2202.7%
2016 -158.84 Thousand CAD 0.0%

Peer Net Income Comparison of Curaleaf Holdings, Inc.

Name Net Income Net Income Difference
Aurora Cannabis Inc. -69.32 Million CAD -305.615%
Avicanna Inc. -8.74 Million CAD -3116.252%
Avant Brands Inc. -5.07 Million CAD -5446.292%
Cardiol Therapeutics Inc. -28.12 Million CAD -899.695%
Crescita Therapeutics Inc. -1.98 Million CAD -14058.963%
Knight Therapeutics Inc. -16.83 Million CAD -1570.312%
MediPharm Labs Corp. -13.08 Million CAD -2049.331%
OrganiGram Holdings Inc. -229.47 Million CAD -22.538%
Canopy Growth Corporation -657.26 Million CAD 57.217%
Willow Biosciences Inc. -13.02 Million CAD -2058.239%
Auxly Cannabis Group Inc. -44.51 Million CAD -531.747%